Abstract
Recent improvements in radioactive seed implantation techniques have established prostate brachytherapy as a highly effective treatment modality for localized prostate cancer, with long-term local and biochemical control similar to outcomes observed after radical prostatectomy and external beam radiation therapy.
Keywords
- Rectal Bleeding
- International Prostate Symptom Score
- Radiation Therapy Oncology Group
- Prostate Brachytherapy
- Radiation Proctitis
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Arterbery VE, Wallner K, Roy J, Fuks Z (1993) Short – term morbidity from CT-planned transperineal 125J prostate implants. Int J Radiat Oncol Biol Phys 25:661–667
Benoit RM, Naslund M, Cohen JL (2000) Complications after prostate brachytherapy in the Medicare population. Urology 55:91–96
Beyer DC, Priestly JB Jr (1997) Biochemical disease-free survival following I-125 prostate implantation. Int J Radiat Oncol Biol Phys 37:559–563
Bottomley D, Ash D, Al-Quaisieh B et al (2007) Side effects of permanent I125 prostate seed implants in 667 patients treated in Leeds. Radiother Oncol 82:46–49
Brown D, Colonias A, Miller R, Benoit R, Cohen J, Arshoun Y (2000) Urinary morbidity with a modified peripheral loading technique of transperineal 125J implantation. Int J Radiat Oncol Biol Phys 47:353–361
Davis JD, Horwitz EM, Lee RW et al (2012) American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy. Brachytherapy 11:6–19
Gelblum DY, Potters L (2000) Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys 48:119–124
Gelblum DY, Potters L, Ashley R, Waldbaum R, Wang XH, Leibel S (1999) Urinary morbidity following ultrasound-guided transperineal prostate seed implantation. Int J Radiat Oncol Biol Phys 45:59–65
Grimm P, Billiet I, Bostwick D, Dicker A, Frank S, Immerzeel J, Keyes M, Kupelian P, Lee WR, Machtens S et al (2012) Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. BJU Int 109(Suppl 1):22–29
Kao J, Stock RG, Stone NN (2000) Long-term erectile function following real-time ultrasound-guided brachytherapy for prostate cancer. J Urol 163:1276 (abstract)
Keyes M, Spadinger I, Liu M et al (2012) Rectal toxicity and rectal dosimetry in low-dose-rate iodine-125 permanent prostate implants: a long-term study in 1006 patients. Brachytherapy 11(3):199–208
Kleinberg L, Wallner K, Roy J, Zelefsky M, Artebery VE (1994) Treatment-related symptoms during the first year following transperineal 125J prostate implantation. Int J Radiat Oncol Biol Phys 28:985–991
Machtens S, Baumann R, Hagemann J et al (2006a) Long-term results of interstitial brachytherapy (LDR-brachytherapy) in the treatment of patients with prostate cancer. World J Urol 24(3):289–295
Machtens S, Karstens JH, Baumann R, Jonas U (2006b) Interstitial brachytherapy (LDR-brachytherapy) in the treatment of patients with prostate cancer. Eur Urol Suppl 5:514–521
Merrick GS, Butler WM, Lief JH, Stipetich RL, Abel LJ, Dorsey AT (1999) Efficacy of sildenafil citrate in prostate brachytherapy patients with erectile dysfunction. Urology 53:1112–1116
Merrick GS, Butler WM, Lief JH, Dorsey LT (2000) Temporal resolution of urinary morbidity following prostate brachytherapy. Int J Radiat Oncol Biol Phys 47:121–126
Merrick GS, Butler WM, Galbreath RW, Stipetich RL, Abel LJ, Lief JH (2002a) Erectile function after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 52:893–902
Merrick GS, Butler WM, Wallner KE (2002b) The importance of radiation doses to the penile bulb vs. crura in the development of postbrachytherapy erectile dysfunction. Int J Radiat Oncol Biol Phys 54:1055–1062
Nag S, Scaperoth DD, Badalament R, Hall SA, Burgers J (1995) Transperineal palladium-103 prostate brachytherapy: analysis of morbidity and seed migration. Urology 45:87–92
Potters L, Torre T, Fearn PA, Leibel SA, Kattan MW (2001) Potency after permanent prostate brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 50:1235–1242
Ragde H, Blasko JC, Grimm PD, Kenny GM, Sylvester JE (1997) Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma. Cancer 80:442–448
Shah JN, Ennis RD (2006) Rectal toxicity profile after transperineal interstitial permanent prostate brachytherapy: use of a comprehensive toxicity scoring system and identification of rectal dosimetric toxicity predictors. Int J Radiat Oncol Biol Phys 64:817–824
Stember DS, Mulhall JP (2012) The concept of erectile function preservation (penile rehabilitation) in the patient after brachytherapy for prostate cancer. Brachytherapy 11:87–96
Stock RG, Kao J, Stone NN (2001) Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer. J Urol 165(2001):436–439
Storey MR, Landgren RC, Cottone R (1999) Transperineal iodine-125 implantation for treatment of clinically localized prostate cancer: 5-year tumor control and morbidity. Int J Radiat Oncol Biol Phys 43:565–571
Terk MD, Stock RG, Stone NN (1998) Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol 160:1379–1382
Theodorescu D, Gillenwater JY, Schneider BF, Koutrouvelis PG (2000) Prostatourethral-rectal fistula following prostate brachytherapy: incidence and risk factors. J Urol 163:1294 (abstract)
Wallner K, Roy J, Harrison L (1996) Tumor control and morbidity following transperineal iodine-125 implantation for stage T1/T2 prostatic carcinoma. J Clin Oncol 14:449–453
Wallner K, Lee H, Wassermann S, Dattoli M (1997) Low risk of urinary incontinence following prostate brachytherapy in patients with prior transurethral resection. Int J Radiat Oncol Biol Phys 37:565–569
Waterman FM, Dicker AP (2003) Probability of late rectal morbidity in 125 I prostate brachytherapy. Int J Radiat Oncol Biol Phys 55:342–353
Zeitlin SI, Sherman J, Raboy A, Lederman G, Albert P (1998) High dose combination radiotherapy for the treatment of localized prostate cancer. J Urol 160:91–95
Zelefsky MJ, Wallner KE, Ling CC, Raben A, Hollister T, Wolfe T (1999) Comparison of 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J Clin Oncol 17:517–523
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Machtens, S. (2013). Incidence and Prognostic Factors for Complications After Permanent Interstitial Brachytherapy. In: Kovács, G., Hoskin, P. (eds) Interstitial Prostate Brachytherapy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-36499-0_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-36499-0_18
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-36498-3
Online ISBN: 978-3-642-36499-0
eBook Packages: MedicineMedicine (R0)